Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure

Hui Dong, Mary L. Earle, Yanfen Jiang, Kathy A. Loutzenhiser, Christopher Triggle

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

1. The cardiovascular effects of CPU-23 (1-{1-[(6-methoxy)-naphth-2-yl]}-ethyl-2-(1-piperidinyl)-acetyl-6,7-dimethoxy -1,2,3,4-tetrahydroisoquinoline), a cleavage product of tetrandrine, were investigated using the whole cell perforated patch-clamp technique, in vitro tension measurements and in vivo haemodynamic recordings. 2. CPU-23 (1 and 10 μM) dose-dependently reduced concentration-response curves for KCl and phenylephrine (PE) in the rat tail artery; inhibition of KCl-induced contraction was much more potent than for PE. At the same concentrations, CPU-23 inhibited the inward Ba 2+ currents in single smooth muscle cells isolated from the rat tail artery, while CPU-23 (10 μM) produced 95% vasorelaxation of the rat middle cerebral artery preconstricted with BayK 8644. 3. CPU-23 (10 and 30 μM) inhibited the noradrenaline-induced phasic contraction of the rat tail artery in the absence of extracellular Ca 2+ from 40% of control to 23% and 14%, respectively (P < 0.01) and tonic contraction of the artery after addition of Ca 2+ (2 mM) from 100% of control to 83% and 75%, respectively (P < 0.01). In the presence of extracellular Ca 2+ the PE-induced contraction was reduced by CPU-23 (30 and 100 μM) to 27% and 37%, respectively. 4. The haemodynamic profile of CPU-23 in the rat was very similar to diltiazem. At 5 mg kg -1 CPU-23 induced a rapid onset and long-lasting decrease in left ventricular systolic pressure (LVSP), maximal velocity of pressure increase (dP/dt(max)), systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR). When haemodynamic actions of CPU-23, verapamil, diltiazem and nifedipine were compared at equidepressor doses, the order of potency for reducing LVSP and dP/dt(max) was verapamil > CPU-23 = diltiazem > nifedipine and the order of potency for decreasing HR was verapamil = CPU-23 = diltiazem > nifedipine. 5. These data indicate that CPU-23 is a novel calcium channel blocker with unique molecular structure, which exerts antihypertensive and cardiac depressant effects due primarily to its action on L-type voltage-gated calcium channels.

Original languageEnglish
Pages (from-to)1271-1278
Number of pages8
JournalBritish Journal of Pharmacology
Volume122
Issue number7
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

L-Type Calcium Channels
Calcium Channel Blockers
Molecular Structure
Diltiazem
Blood Pressure
Phenylephrine
Nifedipine
Arteries
Verapamil
Tail
tetrandrine
Hemodynamics
Ventricular Pressure
CPU 23
Heart Rate
Anti-Arrhythmia Agents
Middle Cerebral Artery
Patch-Clamp Techniques
Calcium Channels
Vasodilation

Keywords

  • Calcium channel blocker
  • Calcium currents
  • CPU-23
  • Haemodynamics
  • Rat tail artery
  • Vasorelaxation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure. / Dong, Hui; Earle, Mary L.; Jiang, Yanfen; Loutzenhiser, Kathy A.; Triggle, Christopher.

In: British Journal of Pharmacology, Vol. 122, No. 7, 1997, p. 1271-1278.

Research output: Contribution to journalArticle

Dong, Hui ; Earle, Mary L. ; Jiang, Yanfen ; Loutzenhiser, Kathy A. ; Triggle, Christopher. / Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure. In: British Journal of Pharmacology. 1997 ; Vol. 122, No. 7. pp. 1271-1278.
@article{5b2255e7be2c4727a26b1baef6a28c39,
title = "Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure",
abstract = "1. The cardiovascular effects of CPU-23 (1-{1-[(6-methoxy)-naphth-2-yl]}-ethyl-2-(1-piperidinyl)-acetyl-6,7-dimethoxy -1,2,3,4-tetrahydroisoquinoline), a cleavage product of tetrandrine, were investigated using the whole cell perforated patch-clamp technique, in vitro tension measurements and in vivo haemodynamic recordings. 2. CPU-23 (1 and 10 μM) dose-dependently reduced concentration-response curves for KCl and phenylephrine (PE) in the rat tail artery; inhibition of KCl-induced contraction was much more potent than for PE. At the same concentrations, CPU-23 inhibited the inward Ba 2+ currents in single smooth muscle cells isolated from the rat tail artery, while CPU-23 (10 μM) produced 95{\%} vasorelaxation of the rat middle cerebral artery preconstricted with BayK 8644. 3. CPU-23 (10 and 30 μM) inhibited the noradrenaline-induced phasic contraction of the rat tail artery in the absence of extracellular Ca 2+ from 40{\%} of control to 23{\%} and 14{\%}, respectively (P < 0.01) and tonic contraction of the artery after addition of Ca 2+ (2 mM) from 100{\%} of control to 83{\%} and 75{\%}, respectively (P < 0.01). In the presence of extracellular Ca 2+ the PE-induced contraction was reduced by CPU-23 (30 and 100 μM) to 27{\%} and 37{\%}, respectively. 4. The haemodynamic profile of CPU-23 in the rat was very similar to diltiazem. At 5 mg kg -1 CPU-23 induced a rapid onset and long-lasting decrease in left ventricular systolic pressure (LVSP), maximal velocity of pressure increase (dP/dt(max)), systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR). When haemodynamic actions of CPU-23, verapamil, diltiazem and nifedipine were compared at equidepressor doses, the order of potency for reducing LVSP and dP/dt(max) was verapamil > CPU-23 = diltiazem > nifedipine and the order of potency for decreasing HR was verapamil = CPU-23 = diltiazem > nifedipine. 5. These data indicate that CPU-23 is a novel calcium channel blocker with unique molecular structure, which exerts antihypertensive and cardiac depressant effects due primarily to its action on L-type voltage-gated calcium channels.",
keywords = "Calcium channel blocker, Calcium currents, CPU-23, Haemodynamics, Rat tail artery, Vasorelaxation",
author = "Hui Dong and Earle, {Mary L.} and Yanfen Jiang and Loutzenhiser, {Kathy A.} and Christopher Triggle",
year = "1997",
language = "English",
volume = "122",
pages = "1271--1278",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure

AU - Dong, Hui

AU - Earle, Mary L.

AU - Jiang, Yanfen

AU - Loutzenhiser, Kathy A.

AU - Triggle, Christopher

PY - 1997

Y1 - 1997

N2 - 1. The cardiovascular effects of CPU-23 (1-{1-[(6-methoxy)-naphth-2-yl]}-ethyl-2-(1-piperidinyl)-acetyl-6,7-dimethoxy -1,2,3,4-tetrahydroisoquinoline), a cleavage product of tetrandrine, were investigated using the whole cell perforated patch-clamp technique, in vitro tension measurements and in vivo haemodynamic recordings. 2. CPU-23 (1 and 10 μM) dose-dependently reduced concentration-response curves for KCl and phenylephrine (PE) in the rat tail artery; inhibition of KCl-induced contraction was much more potent than for PE. At the same concentrations, CPU-23 inhibited the inward Ba 2+ currents in single smooth muscle cells isolated from the rat tail artery, while CPU-23 (10 μM) produced 95% vasorelaxation of the rat middle cerebral artery preconstricted with BayK 8644. 3. CPU-23 (10 and 30 μM) inhibited the noradrenaline-induced phasic contraction of the rat tail artery in the absence of extracellular Ca 2+ from 40% of control to 23% and 14%, respectively (P < 0.01) and tonic contraction of the artery after addition of Ca 2+ (2 mM) from 100% of control to 83% and 75%, respectively (P < 0.01). In the presence of extracellular Ca 2+ the PE-induced contraction was reduced by CPU-23 (30 and 100 μM) to 27% and 37%, respectively. 4. The haemodynamic profile of CPU-23 in the rat was very similar to diltiazem. At 5 mg kg -1 CPU-23 induced a rapid onset and long-lasting decrease in left ventricular systolic pressure (LVSP), maximal velocity of pressure increase (dP/dt(max)), systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR). When haemodynamic actions of CPU-23, verapamil, diltiazem and nifedipine were compared at equidepressor doses, the order of potency for reducing LVSP and dP/dt(max) was verapamil > CPU-23 = diltiazem > nifedipine and the order of potency for decreasing HR was verapamil = CPU-23 = diltiazem > nifedipine. 5. These data indicate that CPU-23 is a novel calcium channel blocker with unique molecular structure, which exerts antihypertensive and cardiac depressant effects due primarily to its action on L-type voltage-gated calcium channels.

AB - 1. The cardiovascular effects of CPU-23 (1-{1-[(6-methoxy)-naphth-2-yl]}-ethyl-2-(1-piperidinyl)-acetyl-6,7-dimethoxy -1,2,3,4-tetrahydroisoquinoline), a cleavage product of tetrandrine, were investigated using the whole cell perforated patch-clamp technique, in vitro tension measurements and in vivo haemodynamic recordings. 2. CPU-23 (1 and 10 μM) dose-dependently reduced concentration-response curves for KCl and phenylephrine (PE) in the rat tail artery; inhibition of KCl-induced contraction was much more potent than for PE. At the same concentrations, CPU-23 inhibited the inward Ba 2+ currents in single smooth muscle cells isolated from the rat tail artery, while CPU-23 (10 μM) produced 95% vasorelaxation of the rat middle cerebral artery preconstricted with BayK 8644. 3. CPU-23 (10 and 30 μM) inhibited the noradrenaline-induced phasic contraction of the rat tail artery in the absence of extracellular Ca 2+ from 40% of control to 23% and 14%, respectively (P < 0.01) and tonic contraction of the artery after addition of Ca 2+ (2 mM) from 100% of control to 83% and 75%, respectively (P < 0.01). In the presence of extracellular Ca 2+ the PE-induced contraction was reduced by CPU-23 (30 and 100 μM) to 27% and 37%, respectively. 4. The haemodynamic profile of CPU-23 in the rat was very similar to diltiazem. At 5 mg kg -1 CPU-23 induced a rapid onset and long-lasting decrease in left ventricular systolic pressure (LVSP), maximal velocity of pressure increase (dP/dt(max)), systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR). When haemodynamic actions of CPU-23, verapamil, diltiazem and nifedipine were compared at equidepressor doses, the order of potency for reducing LVSP and dP/dt(max) was verapamil > CPU-23 = diltiazem > nifedipine and the order of potency for decreasing HR was verapamil = CPU-23 = diltiazem > nifedipine. 5. These data indicate that CPU-23 is a novel calcium channel blocker with unique molecular structure, which exerts antihypertensive and cardiac depressant effects due primarily to its action on L-type voltage-gated calcium channels.

KW - Calcium channel blocker

KW - Calcium currents

KW - CPU-23

KW - Haemodynamics

KW - Rat tail artery

KW - Vasorelaxation

UR - http://www.scopus.com/inward/record.url?scp=0030780741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030780741&partnerID=8YFLogxK

M3 - Article

C2 - 9421272

AN - SCOPUS:0030780741

VL - 122

SP - 1271

EP - 1278

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 7

ER -